Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACME Biopharma is a prominent Indian pharmaceutical company and Contract Development and Manufacturing Organization (CDMO) that specializes in the development and manufacture of complex generic formulations. As a key division of the ACME Group, the company operates high-capacity, regulatory-compliant facilities in Baddi, India, which are approved by major international agencies including the US FDA and EU GMP. ACME Biopharma is a market leader in hormonal products, including oral contraceptives and infertility treatments, and maintains a significant presence in the oncology and sterile injectable segments. The company provides comprehensive services ranging from formulation R&D to commercial-scale production, supporting global pharmaceutical partners with high-quality, cost-effective manufacturing solutions. Their business model focuses on delivering value-added medicines and complex generics to both domestic and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACME Biopharma.